American Funds Washington Mutual Investors Fund Class F-1 WSHFX

American Funds Washington Mutual benefits from a seasoned management team, deep resources, and a time-tested investment approach, making it a solid large-cap option.

While the strategy underwent a prudent leadership transition at the start of 2026, it remains firmly in veteran hands. Assets are allocated between Capital International Investors and Capital World Investors. Eric Stern oversees the overall strategy and CII’s side alongside Mark Casey, Irfan Furniturewala, and Aline Avzaradel, while Jin Lee leads CWI’s team of Alan Berro, Emme Kozloff, and Diana Wagner. Berro handed off leadership duties to Stern at the beginning of 2026, which helped pave the way for his eventual retirement. Except for Avzaradel, all managers have more than a decade of experience on the strategy and are supported by research teams totaling more than 100 analysts combined.

The strategy’s proven investment approach centers on income and quality. It emphasizes US investment-grade companies with long records of dividend payments, though leadership has thoughtfully adapted the guidelines in response to major market shifts. Managers may allocate a limited portion of assets to non-dividend-payers that exhibit strong profitability and modest leverage relative to peers.

While this quality-and dividend-focused approach can leave the strategy out of step with a pure large-value play, it has historically delivered a less volatile portfolio that holds up well in downturns. Since Berro’s 1997 start, the fund has outperformed the S&P 500 prospectus benchmark in virtually every market correction of 10% or more. During the tariff-driven pullback in early 2025, for instance, the strategy fell 11.8%, compared with losses of 17% for the prospectus benchmark, 15% for the large-value Morningstar Category norm, and 15.6% for the Russell 1000 Value Index category benchmark. Strong stock selection in healthcare and industrials—including CVS Health, Northrop Grumman, and GE Aerospace—helped cushion results. That said, the fund has typically lagged during growth-driven rallies and has trailed both benchmarks since the April 2025 rally through May 2026.

Overall, this remains a top-tier conservative large-cap strategy with strong prospects to build on its long record of success.

This fund’s strict inclusion requirements have proved their worth, meriting an Above Average Process rating. Founded in 1952, the fund uses an investment discipline rooted in rules developed in the aftermath of the Great Depression to promote prudent stewardship of capital. Potential holdings must clear several well-defined hurdles.

The criteria emphasize income and quality. In seeking a dividend yield after fees that matches or exceeds that of the S&P 500, the fund primarily invests in US investment-grade companies with a long history of paying dividends. Most portfolio holdings have paid dividends in at least eight of the past 10 years and earned sufficient profits to cover them in four of the past five years, which generally disqualifies those that have borrowed to cover their dividends.

Over time, the guidelines have evolved to allow measured flexibility. Managers may invest up to 5% of assets in companies that have paid dividends for at least five years and demonstrate a strong likelihood of reaching the eight-year threshold. Managers may allocate an additional 5% to non-dividend-payers that exhibit superior ongoing profitability and modest leverage relative to industry peers. Non-US stocks may account for up to 10% of the portfolio, while the fund caps its cash position at 5%. The overall recipe has consistently produced strong downside protection while retaining enough upside to outperform over a market cycle.

The strategy’s focus on dividends leads to a more value-oriented portfolio relative to its S&P 500 prospectus benchmark and has typically landed near the value-blend border of the Morningstar Style Box. The strategy holds roughly 190 businesses that are typically highly profitable and competitively advantaged. As of March 2026, roughly 95% of the companies carried a wide or narrow Morningstar Economic Moat Rating, a proportion that ranked in the top third of the category.

Stock selection drives the portfolio’s sector exposures. Relative to both the prospectus index and the Russell 1000 Value Index category benchmark, the strategy has typically overweighted industrials with companies such as RTX Corp and GE Aerospace. As of March 2026, the fund’s 15% stake in financials was 3.3 percentage points more than the S&P 500’s share but 4 percentage points underweight the value index’s. The fund typically has a notable allocation to technology—its recent 20% was about 6 percentage points overweight the value index, but about 15 percentage points underweight the S&P 500.

The strategy’s focus on established dividend-payers comes through in the portfolio. The portfolio’s average market cap ranks in the top quintile of large-value peers as of March 2026. And the fund’s forecast dividend yield was roughly 2%, which was about 60% more than the S&P 500’s 1.2% and on par with the value index.

The managers also hold a meaningful amount of assets overseas. The strategy has typically held roughly 5% to 10% of assets in non-US holdings, like British American Tobacco and Dutch firm ASML Holding, though the companies need to derive significant revenue from the US to be eligible.

Capital Group’s multimanager approach is well-suited to overseeing the fund’s roughly USD 215 billion asset base, making it the largest actively managed strategy in the large-value category. The fund’s High People rating reflects the firm’s organizational strengths as well as the managers’ experience, skill, and personal investment in the strategy.

Although the strategy underwent a prudent leadership transition at the start of 2026, it remains firmly in the hands of seasoned veterans. The firm splits these assets between subsidiaries Capital World Investors and Capital International Investors. Longtime leader Alan Berro handed off leadership duties to Eric Stern, while Jin Lee assumed CWI’s lead role, in charge of allocating capital across the management team, in January 2026. Stern has led CII’s side for several years, making the transition to lead the entire strategy a smooth one, and Lee’s 12 years on the strategy leave him well-prepared for his expanded role. Berro remains involved.

A core group of veteran leaders anchors the team. Stern heads up the overall strategy and CII’s side, working alongside Mark Casey, Irfan Furniturewala, and Aline Avzaradel. Lee leads CWI’s team of Berro, Emme Kozloff, and Diana Wagner. All managers except for Avzaradel have more than 10 years of experience on the strategy. Based in Los Angeles, San Francisco, and New York, each manager runs a distinct portfolio sleeve, with Stern and Lee helping to ensure their investing styles complement one another. Both the CWI and CII teams draw on the insights of roughly 50 analysts, with each analyst group also managing its own portion of the portfolio.

Each manager invests more than USD 1 million in the fund except for Avzaradel.

Capital Group stands out from the pack as it enhances capabilities around strong core competencies. It earns a High Parent rating.

Since 1931, Capital Group, parent of American Funds, has thoughtfully built out capabilities to become one of the world’s largest asset managers, managing more than USD 3 trillion dollars. Building on the success of its long-term-oriented, multiple-manager system for global equities, the firm has developed robust fixed-income and multi-asset units, each managing more than USD 500 billion. In January 2026, as part of its periodic review of its now five distinct research organizations, Capital Group implemented changes to its equity investment subsidiaries. This exercise resulted in most equity strategies having at least one portfolio manager change, but according to the firm, it better balances each of Capital Group’s three equity groups in terms of investment breadth and helps the firm better align leadership opportunities across the groups. These kinds of shifts have occurred before, with the last coming in 2018.

Capital Group has also turned its attention to some modern opportunities. To address public/private market convergence trends, it launched in April 2025 two semiliquid funds with private market giant KKR. In keeping with its signature portfolio management approach, it splits those funds into multiple sleeves, which are managed independently by distinct managers at each firm. Capital Group plans to deepen this relationship with target-date and model portfolios, as well as public/private equity funds. On the other end of the spectrum, although the firm is firmly dedicated to active management, it has also acknowledged investor preference for passive investing and has thus partnered with indexing stalwarts Vanguard, BlackRock, and Schwab on active/passive models. Capital Group’s proven investment prowess, strong reputation among investors, and scale mean it can be selective with its partnerships.

In addressing another recent trend, since early 2022, the firm has launched more than 25 active exchange-traded funds globally, most of which are distinct, but several are similar to some of its legacy American Funds mutual funds. Unlike some of its peers, though, it has not filed for SEC exemptive relief to offer ETFs as a share class.

That’s a lot of change for such a storied and sizable firm, but Capital Group has a long history of serving investors well.

The fund’s conservative posture and income orientation have performed well since longest-tenured manager Alan Berro’s July 1997 start. From that time through May 2026, the R6 shares’ 9.5% annualized gain beat the fund’s current large-value and former large-blend category peer norms by 1.9 and 1.0 percentage points, respectively. It narrowly lagged the S&P 500’s 9.7% but bested the Russell 1000 Value Index’s 8.7%. Thanks to below-average volatility, as measured by standard deviation, its risk-adjusted results were superior to the indexes and category peers during that period.

The strategy has succeeded by losing less in down markets. For example, in early 2025’s tariff-uncertainty-driven market pullback, the strategy lost 11.8% versus the prospectus index’s 17%, the value index’s 15.6%, and the value category norm’s 15%. The strategy had strong picks in healthcare and industrials such as CVS Health, Northrop Grumman, and GE Aerospace. The fund’s performance patterns have been consistent, too. It held up better than the index in virtually every severe market pullback since Berro‘s 1997 start.

Yet the fund doesn’t typically keep up with the index in more growth-fueled rallies. For example, the fund trailed the index in 2023 and 2024 and landed in the bottom half of the peer group both years, in part thanks to smaller stakes in technology companies with small or no dividend yields, such as Nvidia. In the rally from April 2025 through May 2026, the strategy lagged both indexes and the typical large-value peer.

American Funds Washington Mutual F1's Prospectus Adjusted Expense Ratio is 0.63% per year. It places it in the second-cheapest quintile of the Morningstar US Fund Large Value Category, where the median fee is 0.75% per year. This cost positioning translates into a Medalist Rating Price Score of 0.91, which reflects its relative price positioning within the category. The Price Score ranges from -2.50 (most expensive) to +2.50 (cheapest), with higher scores indicating better cost competitiveness.